Market Place
Sourcing Support
Pfizer tacks on $1B to 2024 revenue outlook amid cost-cutting drive
31 Jul 2024 //
PRESS RELEASE
Pfizer to press pause on large M&A deals, CEO says
11 Jun 2024 //
FIERCE PHARMA
Pfizer shares the ADC data that convinced it to start a Phase 3 lung cancer trial
24 May 2024 //
ENDPTS
Pfizer telegraphs another round of Seagen layoffs
09 May 2024 //
FIERCE PHARMA
Pfizer lifts profit view on cost cuts, demand for COVID products
02 May 2024 //
REUTERS
Seagen’s former commercial chief joins the board at healthcare agency
22 Mar 2024 //
ENDPTS
Seagen patent invalidated in long-running Daiichi Sankyo spat
18 Jan 2024 //
FIERCE PHARMA
Patent Office Invalidates Seagen Patent in Dispute between Daiichi and Seagen
16 Jan 2024 //
BUSINESSWIRE
Pfizer`s $43B buyout of ADC specialist Seagen is a done deal
14 Dec 2023 //
FIERCE PHARMA
Pfizer gets OK for $43-billion Seagen deal after donating cancer drug rights
13 Dec 2023 //
REUTERS
TUKYSA® Improves Progression-Free Survival in Patients with Breast Cancer
06 Dec 2023 //
BUSINESSWIRE
Overall survival data blur Seagen`s Tukysa-ADC path
06 Dec 2023 //
FIERCE PHARMA
Seagen Highlights First Solid Tumor Data for an ADCETRIS
03 Nov 2023 //
BUSINESSWIRE
Data for ADCETRIS with Combination in Hodgkin Lymphoma to be Featured
02 Nov 2023 //
BUSINESSWIRE
Seagen Third Quarter 2023 Financial Results Reflect Strong Product Sales Growth
01 Nov 2023 //
BUSINESSWIRE
EV-302 Trial Extends OS in Patients Treated with PADCEV & KEYTRUDA in Bladder Cancer
22 Oct 2023 //
BUSINESSWIRE
Pfizer’s $43 billion purchase of Seagen gets green light from EU antitrust
20 Oct 2023 //
CNBCTV18
District Court issues final judgment in patent dispute between Daiichi & Seagen
19 Oct 2023 //
PHRAMABIZ
ESMO: Padcev-Keytruda combo nearly doubles survival in key trial
18 Oct 2023 //
FIERCE PHARMA
Seagen to Highlight Overall Survival Data for PADCEV® and TIVDAK®
16 Oct 2023 //
BUSINESSWIRE
Seagen to Report Third Quarter 2023 Financial Results on November 1, 2023
12 Oct 2023 //
BUSINESSWIRE
Padcev, Keytruda combo posts `practice-changing` win
23 Sep 2023 //
FIERCE PHARMA
Nurix Announces Collaboration with Seagen Combining Leading Technologies
07 Sep 2023 //
GLOBENEWSWIRE
Genmab, Seagen say Tivdak cervical cancer trial met overall survival endpoint
05 Sep 2023 //
GLOBENEWSWIRE
Seagen`s breast cancer drug Tukysa boosts Roche`s ADC
17 Aug 2023 //
FIERCE PHARMA
Seagen says Tukysa combo hits main goal in Phase III breast cancer study
17 Aug 2023 //
BUSINESSWIRE
Seagen puts $1.6B Merck-partnered ADC on the back burner
03 Aug 2023 //
FIERCE BIOTECH
Seagen Second Quarter 2023 Financial Results Demonstrate Commercial Performance
02 Aug 2023 //
BUSINESSWIRE
Pfizer shuffles R&D leadership to prepare for Seagen merger
27 Jul 2023 //
FIERCE BIOTECH
US FTC seeks additional info on Pfizer`s proposed takeover of Seagen
14 Jul 2023 //
REUTERS
FTC says it wants more information about $43B Pfizer-Seagen deal
14 Jul 2023 //
ENDPTS
Seagen to Report Second Quarter 2023 Financial Results on August 2, 2023
12 Jul 2023 //
BUSINESSWIRE
Former Seagen CEO brings company HQ to Seattle after merger
29 Jun 2023 //
BIZJOURNAL
Venetoclax Plus Obinutuzumab Demonstrates Durable Survival Benefit
22 Jun 2023 //
PRESS RELAESE
Ph3 Trial of ADCETRIS® (brentuximab vedotin) with Modified Chemo Regimen Shows
20 Jun 2023 //
BUSINESSWIRE
FDA advisers back XBB-targeted COVID shots for 2023-24 campaign
15 Jun 2023 //
REUTERS
Pfizer refiles Seagen acquisition paperwork
15 Jun 2023 //
ENDPTS
Pfizer withdraws $43B Seagen buyout notification to refile
14 Jun 2023 //
FIERCE PHARMA
6-Year Overall Survival Results Added to Prescribing Information for ADCETRIS
14 Jun 2023 //
BUSINESSWIRE
Seagen touts PhII data for Adcetris combo; A-Alpha partners with Gilead on HIV
13 Jun 2023 //
ENDPTS
Seagen Announces ADCETRIS Plus Novel Immunotherapy Combination Delivers 98% Overall Response Rate
13 Jun 2023 //
BUSINESSWIRE
Second round of inflation-related rebates hits 43 drugs from Amgen and others
09 Jun 2023 //
ENDPTS
Seagen CEO Epstein on his next stop, the Pfizer deal and ADCs
08 Jun 2023 //
FIERCE PHARMA
ASCO: Seagen`s top-selling drug under threat from Opdivo
04 Jun 2023 //
FIERCE PHARMA
Seagen Stockholders Approve Acquisition by Pfizer
30 May 2023 //
BIOSPACE
Pfizer to raise $31 billion for Seagen takeover in largest debt offering
17 May 2023 //
REUTERS
FTC move on Amgen-Horizon doesn`t doom Pfizer-Seagen: analysts
17 May 2023 //
FIERCE PHARMA
Pfizer, Seagen kick off FTC review of $43B merger
15 May 2023 //
FIERCE PHARMA
After Pfizer-Seagen deal, analysts expect more M&A activity
09 May 2023 //
FIERCE PHARMA
Biopharma Bets Big on Antibody-Drug Conjugates
08 May 2023 //
BIOSPACE
Seagen Reports First Quarter 2023 Financial Results
27 Apr 2023 //
BUSINESSWIRE
Seagen to Highlight Data From Oncology Portfolio and Pipeline at the 2023 ASCO
26 Apr 2023 //
BUSINESSWIRE
In $43B buy, Seagen courted Pfizer and played the waiting game
17 Apr 2023 //
FIERCE PHARMA
Seagen to Report First Quarter 2023 Financial Results on April 27, 2023
07 Apr 2023 //
BUSINESSWIRE
Merck and Seagen`s Padcev-Keytruda combo wins bladder cancer nod
04 Apr 2023 //
PRESS RELEASE
Former Seagen CEO takes new role less than a year after arrest
23 Mar 2023 //
FIERCE BIOTECH
Seagen quietly doles out cell therapy patent rights, but scope remains unclear
16 Mar 2023 //
ENDPTS
US government to impose inflation penalties on 27 drugs
16 Mar 2023 //
REUTERS
